Literature DB >> 2229230

Reversed-phase high-performance liquid chromatographic separation of synthetic phosphopeptide isomers.

L Otvos1, I A Tangoren, K Wroblewski, M Hollosi, V M Lee.   

Abstract

Selectively phosphorylated synthetic peptides corresponding to the human neurofilament protein middle-sized subunit, H-Lys-Ser-Pro-Val-Pro-Lys-Ser-Pro-Val-Glu-Glu-Lys-Gly-OH, and its analogues were separated by reversed-phase high-performance liquid chromatography of mixtures consisting of the non-phosphorylated, the diphosphorylated and the two different monophosphorylated isomers. Application of the algorithm for the expected retention times to 4-9 amino acid-long peptide fragments revealed the correct elution order of the monophosphorylated isomers. According to circular dichroism studies, this elution order is also compatible with the possibility of induced conformational orientation on the surface of the bonded phase. Chromatographic analysis of the synthetic phosphorylation reaction indicates that the reaction rates of the two structurally different monophosphorylated peptides are similar, which is in contrast to the in vivo site-directed reaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229230     DOI: 10.1016/s0021-9673(01)89493-0

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells.

Authors:  J K Larson; L Otvos; H C Ertl
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Phosphopeptide elution times in reversed-phase liquid chromatography.

Authors:  Jeongkwon Kim; Konstantinos Petritis; Yufeng Shen; David G Camp; Ronald J Moore; Richard D Smith
Journal:  J Chromatogr A       Date:  2007-09-18       Impact factor: 4.759

3.  The solubilization of model Alzheimer tangles: reversing the beta-sheet conformation induced by aluminum with silicates.

Authors:  G D Fasman; C D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.